RankingsLogo

McKesson Corporation

McKesson Corporation is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

McKesson Corporation is a pharmaceutical distributor. It delivers medicines, vaccines, medical supplies, and health information technology. In addition to deliveries, its business solutions help health providers run more efficiently.

Ticker: MCK

Humankind Value: $52.7 B

Revenue: $256.9 B

Market Cap: $71.7 B

Badge100_2024
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

McKesson Corporation generates positive Humankind Value on balance, thanks to its work in Healthcare R&D ($20.5 B), Pharmaceuticals ($10.8 B), and Medical Services ($10.3 B). The company’s value associated with Healthcare R&D, Pharmaceuticals, and Medical Services contains our estimation of 800,000 additional years lived by people worldwide. This firm can increase its Humankind Value by addressing Workplace Injuries (-$877.4 M) and Greenhouse Gases (-$334.8 M). Workplace Injuries are attributed to this company as a result of its direct business activities. Healthcare R&D, Pharmaceuticals, Medical Services, and Greenhouse Gases are mostly or entirely a result of supply-chain relationships. For this firm, supply chain partners increase an already positive Humankind Value.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings